Serve Robotics Buys Diligent, Launching Moxi Robots in Over 25 Hospitals

SERVSERV

On Jan. 21 Serve Robotics announced acquisition of Diligent Robotics, adding Moxi hospital-delivery robots deployed in over 25 U.S. facilities and expanding its AI platform into indoor healthcare. The Uber‐spinoff has deployed more than 2,000 delivery robots across eight U.S. markets and carries a $26 price target from Northland.

1. Acquisition Broadens Serve Robotics’ Addressable Market

On January 21, Serve Robotics announced the acquisition of Diligent Robotics, marking its first foray into indoor autonomy. Diligent’s Moxi robot, deployed across more than 25 U.S. hospitals, automates tasks such as supply delivery and specimen transport to support nursing staff. By integrating Moxi’s AI-powered capabilities with its existing sidewalk-navigating platform, Serve Robotics gains an entry point into healthcare logistics—a sector that MarketsAndMarkets projects will grow from $2.92 billion in 2025 to $15.26 billion by 2030, representing a 39.2% compound annual growth rate.

2. Rapid Deployment and Geographic Expansion

Since its 2020 spin-off from Uber’s Postmates X division, Serve Robotics has deployed over 2,000 delivery units across eight major U.S. metropolitan areas, including Los Angeles, Miami, Dallas-Fort Worth and Chicago. Its sidewalk robots leverage advanced sensor arrays and machine learning algorithms to navigate urban sidewalks safely, reducing last-mile delivery costs by up to 60% compared to traditional couriers and cutting emissions by an estimated 30% per drop-off.

3. Analyst Bullishness and Undercapitalized Coverage

Despite fewer than ten covering analysts, Serve Robotics enjoys a positive consensus, led by a top-pick recommendation from Northland Capital Markets with a $26 per share target—implying nearly 100% upside from current levels. That outlook predates the Diligent deal, which expands the company’s potential market beyond sidewalk delivery into high-value healthcare workflows, suggesting scope for upward revisions as institutional investors reassess the enlarged revenue opportunity.

Sources

DYF